These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 12771797

  • 1. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS, Derksen E, Gaston K.
    J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2: a therapeutic target for prostate cancer.
    Pruthi RS, Wallen EM.
    Clin Genitourin Cancer; 2005 Dec; 4(3):203-11. PubMed ID: 16425990
    [Abstract] [Full Text] [Related]

  • 3. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA.
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [Abstract] [Full Text] [Related]

  • 4. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N.
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract] [Full Text] [Related]

  • 5. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C, Eltze E, Von Struensee D, Wülfing P, Bode ME, Bettendorf O, Piechota H, Hertle L.
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [Abstract] [Full Text] [Related]

  • 6. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA, Dubois RN.
    Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
    [Abstract] [Full Text] [Related]

  • 7. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers].
    Eschwege P.
    Bull Cancer; 2004 May; 91 Spec No():S113-6. PubMed ID: 15239339
    [Abstract] [Full Text] [Related]

  • 8. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D, Pyo H, Choy H.
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [Abstract] [Full Text] [Related]

  • 9. Why cyclooxygenase-2 inhibition plus chemotherapy?
    Sweeney CJ.
    Am J Clin Oncol; 2003 Aug; 26(4):S122-5. PubMed ID: 12902869
    [Abstract] [Full Text] [Related]

  • 10. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A, Fernandez PM, Chughtai OR, Kaiser HE.
    In Vivo; 2002 Aug; 16(6):501-9. PubMed ID: 12494894
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K, Akay MT, Abbasoglu O, Ercan A.
    Cancer Detect Prev; 2004 Aug; 28(2):127-42. PubMed ID: 15068837
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H.
    Cancer; 2003 Aug 15; 98(4):661-7. PubMed ID: 12910508
    [Abstract] [Full Text] [Related]

  • 13. The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells.
    Grossman EM, Longo WE, Panesar N, Mazuski JE, Kaminski DL.
    Carcinogenesis; 2000 Jul 15; 21(7):1403-9. PubMed ID: 10874020
    [Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 15. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ.
    Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2207-12. PubMed ID: 14640057
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives.
    Dermond O, Rüegg C.
    Drug Resist Updat; 2001 Oct 08; 4(5):314-21. PubMed ID: 11991685
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
    Tuynman JB, Peppelenbosch MP, Richel DJ.
    Crit Rev Oncol Hematol; 2004 Nov 08; 52(2):81-101. PubMed ID: 15501074
    [Abstract] [Full Text] [Related]

  • 20. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers].
    Eschwege P.
    Bull Cancer; 2004 May 08; 91 Suppl 2():S113-6. PubMed ID: 15899635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.